WednesdayJun 29, 2022 2:45 pm

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Focused on International Strategy to Reach ‘Larger Consumer Base’

Flora Growth Corp. (NASDAQ: FLGC) CEO Luis Merchan is quoted in a recent article saying, “International growth is a key objective of our company’s strategy.” Earlier this year, the company completed the acquisition of 100% equity interests of Just Brands LLC and High Roller Private Label LLC, owners of the JustCBD brand, in a move by Flora Growth to explore global expansion opportunities and increase its customer database. The article reads: “By mid-May 2022, Flora Growth had already announced the expansion of its operational footprint in Europe and the United Kingdom to further its international growth strategy… In what marks…

Continue Reading

WednesdayJun 29, 2022 2:21 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging DehydraTECH(TM) to Stand Distinct, Push Brand

Lexaria Bioscience Corp. (NASDAQ: LEXX) acknowledges consumers’ shift away from smoking cigarettes to nicotine alternatives, which has resulted in the growth of the nicotine pouch and nicotine replacement therapy (“NRT”) markets. Through its patented DehydraTECH technology, Lexaria looks to tap into the multibillion-dollar nicotine alternatives industry and stamp its position. “In a move that sought to prove DehydraTECH’s superiority, Lexaria conducted an oral nicotine absorption study in 2021. The research showed that Lexaria’s DehydraTECH-nicotine delivered via an oral pouch product dispensed enough nicotine levels in blood plasma in four minutes, as concentration-matched controls did in 45 minutes. In addition, peak…

Continue Reading

TuesdayJun 28, 2022 2:58 pm

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Pursuing Strategy Against COVID-19, Immune System-Related Maladies

Aditxt (NASDAQ: ADTX) is focused on developing and commercializing technologies to monitor and reprogram the immune system with the ultimate goal of improving patient outcomes for a variety of conditions. “Aditxt is joining the fight against the pandemic while pursuing a larger strategy against immune system-related maladies ranging from seasonal allergies to organ transplant rejection,” a recent article reads. “Aditxt’s first commercial product is an immune monitoring technology trademarked as AditxtScore(TM) for COVID-19, which is designed to provide users with a personalized profile of their immune status – specifically in relation to their vulnerability and immune response regarding COVID’s SARS-CoV-2…

Continue Reading

TuesdayJun 28, 2022 1:10 pm

TinyGemsBreaks – GreenBox POS (NASDAQ: GBOX) Issues Letter to Shareholders

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing financial technology company, today announced a CEO letter to shareholders. In the letter, GBOX Chief Executive Officer Fredi Nisan discussed the company’s maturation over the years and his encouragement in the company’s accomplishments and future. “No doubt, we are keenly aware of volatile changes in the competitive landscape and business environment that have left numerous organizations rethinking their strategy. Nonetheless, we remain laser-focused on the long-term execution of our business strategy, with steadfast confidence in our highly differentiated technology,” Nisan stated. “Our commitment to driving shareholder value is not, and should not,…

Continue Reading

TuesdayJun 28, 2022 12:44 pm

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Adelia Announce Achievement of Milestone

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, a biotechnology company focused on progressing Psychedelics to Therapeutics(TM), and its wholly controlled subsidiary Adelia Therapeutics Inc., have announced the achievement of a key milestone. The milestone is identified as Y2, Q3 in the contribution agreement created between Adelia and Cybin when the company acquired Adelia. Reaching the milestone means that an estimated 37,366.2 class B common shares in Cybin will be issued to Adelia shareholders; the issuance of the shares represents the approximately $217,465 that Cybin agreed to pay if the key milestone was achieved. Adelia…

Continue Reading

MondayJun 27, 2022 2:04 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Expands Collaboration Efforts with Tier 1 Supplier of Automotive Lighting Equipment

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, and Koito Manufacturing Co. Ltd (TSE: 7276), a leading automotive lighting equipment tier-1 supplier, jointly announced their intention to expand existing collaboration efforts to include select future Cepton lidar products and go-to-market activities. According to the update, detailed commercial terms are under discussion. “In the past five years, our team has successfully collaborated with Koito to commercialize and scale the manufacturing of Cepton’s lidar technology,” said Jun Pei, Cepton’s co-founder and CEO. “Expanded collaboration will further strengthen the Koito-Cepton partnership and better positions both companies to…

Continue Reading

MondayJun 27, 2022 1:46 pm

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Moving Forward with Phase 1/2a Clinical Trial after Receiving Key FDA Approval

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has received approval from the U.S. Food and Drug Administration (“FDA”) to proceed with its phase 1/2a first-in-human clinical trial evaluating CYB003; the company has received a “may proceed” letter and investigational new drug application (“IND”) clearance from the FDA. The approval means that CYB003 will be the first  novel psilocybin analog to enter clinical development, with patient recruitment beginning immediately and pharmacokinetic and safety data readout anticipated by fourth quarter 2022. According to the announcement, Cybin’s CYB003 is a proprietary deuterated psilocybin analog being developed for…

Continue Reading

FridayJun 24, 2022 12:23 pm

TinyGemsBreaks – GreenBox POS (NASDAQ: GBOX) Becomes Among Sector’s 1st to Ensure Real-Time Custodial Account Attestations

GreenBox (NASDAQ: GBOX) is a financial technology company that leverages proprietary blockchain security and token technology to deliver customized payment solutions. The company has consistently called for improved processes to make the stablecoin industry custodial and transactional — the two elements GreenBox believes are critical to the industry’s long-term success. Upon completing a rigorous process, GreenBox has announced a partnership with accounting and consulting firm Armanino to attest to all GreenBox custodial accounts in real-time. “I could not be more pleased to see the stablecoin industry and the regulators move in the direction GreenBox has built our company on since…

Continue Reading

ThursdayJun 23, 2022 4:33 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures FDA Approval for Protocol Amendment to Ongoing Potentially Pivotal Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced its receipt of approval from the U.S. Food and Drug Administration (“FDA”) for its ongoing potentially pivotal global study evaluating the efficacy and safety of Berubicin compared with Lomustine (Gleostine) administered after first line therapy for the treatment of recurrent glioblastoma multiforme (“GBM”), one of the most aggressive types of brain cancer. “We are pleased to have received this positive response from the FDA and to continue driving the…

Continue Reading

ThursdayJun 23, 2022 3:11 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Shareholder Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today provided an update to its shareholders, including recent highlights and accomplishments for the company, the Mullen FIVE and the Mullen EV Van programs. Among the various highlights, the company reported that its solid-state polymer battery cell was successfully tested for the second time at Battery Innovation Center (“BIC”) in Indiana. The follow-up testing through an accredited facility shows promise for solid-state polymer cell technology when scaled to the vehicle pack level and used in EVs. “2022 has been an exceptional year for us so far; I am very proud…

Continue Reading

Contact us: (310) 299-1717